Success factors for multiplex molecular testing by EBUS-GS

Success factors for multiplex molecular testing by EBUS-GS - Success factors for multiplex molecular testing by EBUS-GS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000056056

Enrollment

Registered

2024-11-05

Start date

2024-01-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The study included 59 cases in which a pathological diagnosis of non-small cell lung cancer was obtained using EBUS-GS in the respiratory medicine department of our hospital between August 2021 and December 2023, and in which a pathologist at our hospital reviewed whether or not to submit a multi-gene test.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
We evaluated whether pathologists could submit samples to ODxTT or AmoyDx multi-gene testing.	—

Countries

Japan

Contacts

Public ContactKotaro Kajiwara

Matsuyama Red Cross Hospital Department of Respiratory Medicine

respiratory24@outlook.jp0899241111

Outcome results